Janux Therapeutics Stock Market Value
| JANX Stock | USD 36.37 0.80 2.15% |
| Symbol | Janux |
Janux Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Janux Therapeutics. If investors know Janux will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Janux Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.17) | Revenue Per Share | Quarterly Revenue Growth (0.83) | Return On Assets | Return On Equity |
The market value of Janux Therapeutics is measured differently than its book value, which is the value of Janux that is recorded on the company's balance sheet. Investors also form their own opinion of Janux Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Janux Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Janux Therapeutics' market value can be influenced by many factors that don't directly affect Janux Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Janux Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Janux Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Janux Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Janux Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Janux Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Janux Therapeutics.
| 01/17/2025 |
| 02/16/2025 |
If you would invest 0.00 in Janux Therapeutics on January 17, 2025 and sell it all today you would earn a total of 0.00 from holding Janux Therapeutics or generate 0.0% return on investment in Janux Therapeutics over 30 days. Janux Therapeutics is related to or competes with Mineralys Therapeutics,, Anebulo Pharmaceuticals, Rezolute, Keros Therapeutics, Fennec Pharmaceuticals, Edgewise Therapeutics, and Harmony Biosciences. Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell... More
Janux Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Janux Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Janux Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 61.07 | |||
| Value At Risk | (7.99) | |||
| Potential Upside | 8.19 |
Janux Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Janux Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Janux Therapeutics' standard deviation. In reality, there are many statistical measures that can use Janux Therapeutics historical prices to predict the future Janux Therapeutics' volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.37) | |||
| Total Risk Alpha | (0.38) | |||
| Treynor Ratio | (0.16) |
Janux Therapeutics Backtested Returns
Janux Therapeutics holds Efficiency (Sharpe) Ratio of -0.026, which attests that the entity had a -0.026 % return per unit of risk over the last 3 months. Janux Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Janux Therapeutics' Market Risk Adjusted Performance of (0.15), standard deviation of 7.55, and Risk Adjusted Performance of (0.02) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 2.34, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Janux Therapeutics will likely underperform. At this point, Janux Therapeutics has a negative expected return of -0.2%. Please make sure to check out Janux Therapeutics' total risk alpha, kurtosis, as well as the relationship between the Kurtosis and market facilitation index , to decide if Janux Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.51 |
Good reverse predictability
Janux Therapeutics has good reverse predictability. Overlapping area represents the amount of predictability between Janux Therapeutics time series from 17th of January 2025 to 1st of February 2025 and 1st of February 2025 to 16th of February 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Janux Therapeutics price movement. The serial correlation of -0.51 indicates that about 51.0% of current Janux Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.51 | |
| Spearman Rank Test | -0.23 | |
| Residual Average | 0.0 | |
| Price Variance | 7.41 |
Janux Therapeutics lagged returns against current returns
Autocorrelation, which is Janux Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Janux Therapeutics' stock expected returns. We can calculate the autocorrelation of Janux Therapeutics returns to help us make a trade decision. For example, suppose you find that Janux Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Janux Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Janux Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Janux Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Janux Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Janux Therapeutics Lagged Returns
When evaluating Janux Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Janux Therapeutics stock have on its future price. Janux Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Janux Therapeutics autocorrelation shows the relationship between Janux Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Janux Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Janux Stock Analysis
When running Janux Therapeutics' price analysis, check to measure Janux Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Janux Therapeutics is operating at the current time. Most of Janux Therapeutics' value examination focuses on studying past and present price action to predict the probability of Janux Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Janux Therapeutics' price. Additionally, you may evaluate how the addition of Janux Therapeutics to your portfolios can decrease your overall portfolio volatility.